Sucralose & Sucralose Excipient Excipient Use in Tablet Orally Disintegrating Delayed Release Dosage Forms

Sucralose

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

4 Listed Products, 1 Bioplus Life Sciences, 1 Gangwal Healthcare, 1 Pharm-RX Chemical, 1 Rochem International Inc

REGULATORY FILINGS

5 Suppliers, 2 USDMF, 1 NDC API, 3 Listed Suppliers

SOLUTIONS BY APPLICATIONS

2 Taste Masking

2 Taste Masking

ANALYTICAL SOLUTION(s)

1 USP Standards, 1 Other Ref. Standards

FINISHED FORMULATIONS

93 ORAL, 23 TABLET, 21 SOLUTION, 13 SUSPENSION, 11 BUCCAL, 11 GUM, CHEWING, 8 SYRUP, 7 TABLET, ORALLY DISINTEGRATING, 5 SUBLINGUAL, 5 TABLET, CHEWABLE, 3 FILM, 3 FOR SOLUTION, 3 FOR SUSPENSION, 3 NASAL, 3 SPRAY, METERED, 3 TROCHE/LOZENGE, 2 FOR SUSPENSION, EXTENDED RELEASE, 2 ORAL-28, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 CAPSULE, 1 CONCENTRATE, 1 ORAL, RECTAL, 1 POWDER, 1 SUSPENSION, EXTENDED RELEASE, 1 TABLET, DELAYED RELEASE, 1 TABLET, EFFERVESCENT, 1 TABLET, FOR SUSPENSION, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE